1. Home
  2. ESQ vs WVE Comparison

ESQ vs WVE Comparison

Compare ESQ & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

N/A

Current Price

$124.09

Market Cap

941.0M

Sector

Finance

ML Signal

N/A

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$5.09

Market Cap

994.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ESQ
WVE
Founded
2006
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
941.0M
994.1M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
ESQ
WVE
Price
$124.09
$5.09
Analyst Decision
Buy
Strong Buy
Analyst Count
3
16
Target Price
$120.33
$29.81
AVG Volume (30 Days)
128.6K
2.9M
Earning Date
04-23-2026
04-28-2026
Dividend Yield
0.76%
N/A
EPS Growth
14.20
N/A
EPS
2.89
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
$35.15
N/A
Revenue Next Year
$39.09
$85.67
P/E Ratio
$44.31
N/A
Revenue Growth
N/A
149.43
52 Week Low
$92.33
$5.01
52 Week High
$134.65
$21.73

Technical Indicators

Market Signals
Indicator
ESQ
WVE
Relative Strength Index (RSI) 51.97 39.41
Support Level $103.79 N/A
Resistance Level $134.03 $6.39
Average True Range (ATR) 3.71 0.36
MACD -0.55 -0.06
Stochastic Oscillator 12.76 16.07

Price Performance

Historical Comparison
ESQ
WVE

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: